Muestra la distribución de su producción desde 2008 por disciplinas.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Institución | Ctr New Drugs Hypertens CENDHY |
| WOS | #Pub |
|---|---|
| Chemistry, Physical | 12 |
| Chemistry, Multidisciplinary | 11 |
| Pharmacology & Pharmacy | 11 |
| Physics, Atomic, Molecular & Chemical | 8 |
| Medicine, Research & Experimental | 4 |
| Biochemistry & Molecular Biology | 4 |
| Nanoscience & Nanotechnology | 3 |
| Crystallography | 3 |
| Computer Science, Interdisciplinary Applications | 2 |
| Materials Science, Multidisciplinary | 2 |
| Immunology | 2 |
| Physics, Applied | 1 |
| Materials Science, Biomaterials | 1 |
| Biotechnology & Applied Microbiology | 1 |
| Quantum Science & Technology | 1 |
| Polymer Science | 1 |
| Chemistry, Medicinal | 1 |
| Biophysics | 1 |
| Mathematics, Interdisciplinary Applications | 1 |
| Chemistry, Inorganic & Nuclear | 1 |
| Microbiology | 1 |
| Toxicology | 1 |
| Engineering, Chemical | 1 |
| Biochemical Research Methods | 1 |
| Chemistry, Organic | 1 |
| Chemistry, Applied | 1 |
| Thermodynamics | 1 |
| Computer Science, Information Systems | 1 |
| Mathematical & Computational Biology | 1 |
| Scopus | #Pub |
|---|---|
| Pharmaceutical Science | 5 |
| Biotechnology | 2 |
| Physical And Theoretical Chemistry | 2 |
| Spectroscopy | 1 |
| Chemistry (All) | 1 |
| Surfaces And Interfaces | 1 |
| Condensed Matter Physics | 1 |
| Energy (All) | 1 |
| Atomic And Molecular Physics, And Optics | 1 |
| Computer Graphics And Computer Aided Design | 1 |
| Chemical Engineering (All) | 1 |
| Biochemistry | 1 |
| Structural Biology | 1 |
| Nuclear And High Energy Physics | 1 |
| Colloid And Surface Chemistry | 1 |
| Materials Chemistry | 1 |
| Molecular Biology | 1 |
| Economics And Econometrics | 1 |
| SciELO | #Pub |
|---|
| Publicaciones | Citas | ||||
|---|---|---|---|---|---|
| Total | Porcentaje | Total | Porcentaje | Representativas Cuartil (Mediana) | |
| Q1 | 9 | 39.1 % | 121 | 49.4 % | 12 |
| Q2 | 12 | 52.2 % | 115 | 46.9 % | 10 |
| Q3 | 2 | 8.7 % | 9 | 3.7 % | 9 |
| Q4 | 0 | 0.0 % | 0 | 0.0 % | |